BostonGene Recognized by Frost Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions
- Written by PR Newswire
Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology
SAN ANTONIO, Jan. 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the AI-driven...














